Biomedical Engineering Reference
In-Depth Information
[3] P.V. Rao, A.P. Reddy, X. Lu, S. Dasari, A. Krishnaprasad, E Biggs, et al., Proteomic identification of
salivary biomarkers of type-2 diabetes, J. Proteome Res. 8 (1) (2009) 239
245.
[4] T. Pfaffe, J. Cooper-White, P. Beyerlein, K. Kostner, C. Punyadeera, et al., Diagnostic potential of
saliva: current state and future applications, Clin. Chem. 57 (5) (2011) 675
687.
[5] F. Bouwman, et al., 2D-electrophoresis and multiplex immunoassay proteomic analysis of different body
fluids and cellular components reveal known and novel markers for extended fasting, BMC Med.
Genomics 4 (1) (2011) 24.
[6] W. Yan, et al., Systematic comparison of the human saliva and plasma proteomes, Proteomics Clin.
Appl. 3 (1) (2009) 116
134.
[7] S. Bandhakavi, et al., A dynamic range compression and three-dimensional peptide fractionation analysis
platform expands proteome coverage and the diagnostic potential of whole saliva, J. Proteome Res. 8
(12) (2009) 5590
5600.
[8] J.A. Loo, et al., Comparative human salivary and plasma proteomes, J. Dent. Res. 89 (10) (2010)
1016
1023.
[9] C. Punyadeera, G. Dimeski, K. Kostner, P. Beyerlein, J. Cooper-White, et al., One-step homogeneous
C-reactive protein assay for saliva, J. Immunol. Methods (2011).
[10] N. Christodoulides, M. Sanghamitra, M.S. Craig, L.M. Chris, N. Floriano, P.D. Priya, et al., Application
of microchip assay system for the measurement of C-reactive protein in human saliva, Lab Chip 5 (3)
(2005) 261
269.
[11] P.M. Ridker, C-reactive protein, inflammation, and cardiovascular disease: clinical update, Tex. Heart
Inst. J. 32 (3) (2005) 384
386.
[12] P.M. Ridker, et al., Rosuvastatin to prevent vascular events in men and women with elevated C-reactive
protein, N. Engl. J. Med. 359 (21) (2008) 2195
2207.
[13] H. Arima, et al., High-sensitivity C-reactive protein and coronary heart disease in a general population
of Japanese: the Hisayama study, Arterioscler Thromb Vasc. Biol. 28 (7) (2008) 1385
1391.
[14] C.S. Miller, et al., Salivary biomarkers of existing periodontal disease: a cross-sectional study, J. Am.
Dent. Assoc. 137 (3) (2006) 322
329.
[15] D.A. Ovchinnikov, M.A. Cooper, P. Pandit, W.B. Coman, J. Cooper-White, P. Keith, et al., Tumour-sup-
pressor gene promoter hypermethylation in saliva of head and neck cancer patients. J. Trans. Oncol.,
September 2012.
[16] T. Shpitzer, et al., A comprehensive salivary analysis for oral cancer diagnosis, J. Cancer Res. Clin.
Oncol. 133 (9) (2007) 613
617.
[17] D.T. Wong, Oral cancer and saliva diagnostics,
in: National Oral Health Conference, 2007,
Denver, CO.
[18] S. Hu, et al., Preclinical validation of salivary biomarkers for primary Sj¨gren's syndrome, Arthritis
Care Res. 62 (11) (2010) 1633
1638.
[19] L. Zhang, J.J. Farrell, H. Zhou, D. Elashoff, D. Akin, N.-H. Park, et al., Researchers find biomarkers in saliva
for detection of early-stage pancreatic cancer, Gastroenterology, (138) (2010) 949
957.
[20] C.F. Streckfus, et al., The presence of soluble c-erbB-2 in saliva and serum among women with breast
carcinoma: a preliminary study, Clin. Cancer Res. 6 (6) (2000) 2363
2370.
[21] C.F. Streckfus, et al., Breast cancer related proteins are present in saliva and are modulated secondary to
ductal carcinoma in situ of the breast, Cancer Invest. 26 (2) (2008) 159
167.
[22] M. Castagnola, P.M. Picciotti, I. Messana, C. Fanali, A. Fiorita, T. Cabras, et al., Potential applications
of human saliva as diagnostic fluid, Acta Otorhinolaryngol Ital. 31 (6) (2011) 347
357.
[23] E. Topkas, et al., Evaluation of saliva collection devices for the analysis of proteins, Clin. Chim. Acta
413 (13
14) (2012) 1066
1070.
[24]
J.L. Chicharro, et al., Saliva composition and exercise, Sports Med. 26 (1) (1998) 17
27.
